|Project Title||Master Protocol Development: COVID-19 Natural History|
The COVID-19 Natural History Master Protocol effort involves the development of a protocol designed to identify multiple COVID-19 cohorts to support a variety of on-demand queries and subsequent inferential studies. The protocol will be adaptable to various data sources with clinically rich data and will include specific populations of interest, such as the pediatric population, pregnant women, and other vulnerable populations identified by FDA.
Thursday, June 4, 2020
- Vaccines, Blood & Biologics
- Devices and Radiologic Health